A sign appears in the window of an office at Pfizer Manufacturing in Puurs, Belgium, on Monday, the same day the European Medicines Agency authorized the use of the company’s COVID-19 vaccine.

A sign in the window of an office at Pfizer Manufacturing in Puurs, Belgium on Monday, Dec. 21, 2020. The European Medicines Agency is meeting Monday to consider approving a coronavirus vaccine developed by BioNTech and Pfizer that would be the first to be authorized for use in the European Union. The closed-doors meeting comes weeks after the shot was granted permission under emergency provisions by regulators in Britain and the United States. (AP Photo/Valentin Bianchi)